Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
It has recently been suggested that mood disorders can be characterized by glial pathology as indicated by histopathological postmortem findings. Here, we review studies investigating the glial marker S100B in serum of patients with mood disorders. This protein might act as a growth and differentiation factor. It is located in, and may actively be released by, astro- and oligodendrocytes. Studies consistently show that S100B is elevated in mood disorders; more strongly in major depressive than bipolar disorder. Successful antidepressive treatment reduces S100B in major depression whereas there is no evidence of treatment effects in mania. In contrast to the glial marker S100B, the neuronal marker protein neuron-specific enolase is unaltered. By indicating glial alterations without neuronal changes, serum S100B studies confirm specific glial pathology in mood disorders in vivo. S100B can be regarded as a potential diagnostic biomarker for mood disorders and as a biomarker for successful antidepressive treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 2×
“It has recently been suggested that a loss of neuroplasticity and cellular resilience may underlie the pathophysiology of mood disorders and that optimum long-term treatment can only be achieved by early neurotrophic and/or neuroprotective intervention [1, 2].”
BackgroundDonato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580 · cited 1×
“Protein S100B has been detected in numerous other tissues in the human body besides glial cells, for example, in adipocytes, melanocytes, chondrocytes, myocardium, and Schwann cells [33, 35, 48].”
BackgroundGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“Histopathological post mortem findings [1, 4–6] consistently showed reductions in glial cell density or glial cell numbers in prefrontal brain regions, such as the (subgenual) anterior cingulate cortex, the orbitofrontal cortex, and dorsolateral prefrontal cortex in association with reduced prefrontal gray matter in p…”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“Histopathological post mortem findings [1, 4–6] consistently showed reductions in glial cell density or glial cell numbers in prefrontal brain regions, such as the (subgenual) anterior cingulate cortex, the orbitofrontal cortex, and dorsolateral prefrontal cortex in association with reduced prefrontal gray matter in p…”
BackgroundCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Alterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572 · cited 1×
“It has also been suggested that S100 proteins may play an essential role in the pathogenesis of depression and its treatment [40, 42], and that S100B-related mechanisms could be explored as potential targets for novel antidepressive therapeutics [38, 39].”
BackgroundCzéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · cited 1×
“Remarkably, antidepressive treatment has been shown to successfully reverse reduction in astroglial density in animal models of depression [18].”
BackgroundGlial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369 · cited 1×
“Specific reductions in oligodendrocytes have also been reported for the amygdala in major depressive disorder (MDD) [14], and microglial alterations in bipolar disorder (BD), also including manic episodes [1].”
BackgroundVostrikov, V. M., Uranova, N. A., & Orlovskaya, D. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.014 · Cited by 233 · cited 1×
“Furthermore, alterations were described histopathologically for astrocytes [10–13] and oligodendrocytes [14–16] in these disorders.”
BackgroundSerum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Self-citation
Cited by
Donato, R., R. Cannon, B., Sorci, G., Riuzzi, F., Hsu, K., J. Weber, D., & L. Geczy, C. (2013) · Current Molecular Medicine · doi:10.2174/156652413804486214 · Cited by 1,316
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
“In another study measuring serum levels of neuron-specific enolase, a specific marker of neurons in the CNS, there were no changes in patients with MDD compared to control patients [103, 209].”
BackgroundSacher, J., Neumann, J., Fünfstück, T., Soliman, A., Villringer, A., & Schroeter, M. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.001 · Cited by 411
Self-citationRole of S100 proteins in health and disease
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118677 · Cited by 361
Integrated Neurobiology of Bipolar Disorder
Maletic, V., & Raison, C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00098 · Cited by 226
Metadata
- Authors
- Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., & Mueller, K.
- Venue
- Cardiovascular Psychiatry and Neurology
- Publisher
- Wiley
- Published
- 2010-05-27
- Volume
- 2010
- Pages
- 1-7
- ISSN
- 2090-0163 (ISSN-L)
- 2090-0171
- OpenAlex
- W2017796808
- Cited by
- 71
- References
- 11
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies. https://app.cochat.ai/papers/10.1155/2010/780645
- The paper
- Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., & Mueller, K. (2010). Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies. Cardiovascular Psychiatry and Neurology. https://doi.org/10.1155/2010/780645
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.